Eugenio Battaglia

Eugenio Battaglia

Oct 17, 2014

Group 6 Copy 451
0
    Please wait...

    About This Project

    BioPeers – Peers Center for Biotech and Society
    Our bodies produce very low doses of N,N-Dimethyltryptamine (DMT), a psychotropic substance. Recent findings suggest that DMT is an important modulator of Sig-1R, a receptor that plays important roles in neuropsychiatric diseases like schizophrenia, and depression. This project aims to further develop a hypothesis for the relation between DMT and Sig-1R, in hopes of providing novel insight into these neuropsychiatric diseases.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    How can psoriasis of 125 million people be treated with natural grape polyphenols?

    Our family has a recipe for psoriasis treatment based on grape extract, and we want to help 125 million...

    A randomized and controlled trial to examine the impact of lingual frenotomy on bottle feeding mechanics

    Some babies are born with tongue-tie where an unusually short or tight band of tissue tethers the bottom...

    Early-Stage Drug Discovery for Chagas' Disease

    An estimated 6 – 7 million people in Latin America and 300,000 U.S. citizens are infected with the protozoan...

    Backer Badge Funded